These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7563002)

  • 1. Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model.
    Owusu-Ababio G; Rogers JA; Morck DW; Olson ME
    J Med Microbiol; 1995 Nov; 43(5):368-76. PubMed ID: 7563002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA; Castro GR
    Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of ciprofloxacin microspheres in eradicating bacterial biofilm.
    Owusu-Ababio G; Rogers J; Anwar H
    J Control Release; 1999 Feb; 57(2):151-9. PubMed ID: 9971894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of persistent infection associated with peritoneal implants.
    Ward KH; Olson ME; Lam K; Costerton JW
    J Med Microbiol; 1992 Jun; 36(6):406-13. PubMed ID: 1613780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 7. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS; Helfer VE; Bernardes PM; Macedo AJ; Nielsen EI; Friberg LE; Dalla Costa T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa.
    Saltzstein D; Wachs B; Perroncel R; Benson A; Herrington J; Haverstock D; Pertel P
    J Chemother; 2007 Dec; 19(6):694-702. PubMed ID: 18230553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoporous silica coatings as a drug delivery system for ciprofloxacin: outcome of variable release rates in the infected middle ear of rabbits.
    Hesse D; Ehlert N; Lüenhop T; Smoczek A; Glage S; Behrens P; Müller PP; Esser KH; Lenarz T; Stieve M; Bleich A; Prenzler NK
    Otol Neurotol; 2013 Aug; 34(6):1138-45. PubMed ID: 23598698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for Pseudomonas aeruginosa sinusitis.
    Cho DY; Lim DJ; Mackey C; Skinner D; Weeks C; Gill GS; Hergenrother RW; Swords WE; Woodworth BA
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):482-489. PubMed ID: 29334430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
    Lu Q; Yu J; Bao L; Ran T; Zhong H
    Chemotherapy; 2013; 59(1):51-6. PubMed ID: 23816803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention.
    Norris P; Noble M; Francolini I; Vinogradov AM; Stewart PS; Ratner BD; Costerton JW; Stoodley P
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4272-9. PubMed ID: 16189108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.
    Seth AK; Zhong A; Nguyen KT; Hong SJ; Leung KP; Galiano RD; Mustoe TA
    Wound Repair Regen; 2014; 22(6):712-9. PubMed ID: 25230854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F; Bahamondez-Canas TF; Smyth HDC
    AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F; Bahamondez-Canas TF; Moraga-Espinoza D; Smyth HDC; Watts AB
    Eur J Pharm Biopharm; 2020 Jul; 152():210-217. PubMed ID: 32442738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.
    Growcott EJ; Coulthard A; Amison R; Hardaker EL; Saxena V; Malt L; Jones P; Grevot A; Poll C; Osborne C; Banner KH
    J Cyst Fibros; 2011 May; 10(3):166-74. PubMed ID: 21247812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.